Corium Innovations
- Biotech or pharma, therapeutic R&D
- CMO, CRO
Corium Innovations, Inc. is a leader in the development and manufacture of transdermal systems and oral thin film dosage forms. We work with clients in a variety of partnership types which includes: feasibility, co-development, manufacturing supply and life cycle management. Corium is uniquely positioned amongst its peers in that it is has developed two brand transdermal assets in the therapeutic areas of Ulcerative Colitis, Relapsing Multiple Sclerosis and Pulmonary Arterial Hypertension that are available for commercial licensing in both US and ex-US geographies.